Transcend Wealth Collective LLC Sells 231 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Transcend Wealth Collective LLC lowered its position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2.9% during the first quarter, HoldingsChannel.com reports. The fund owned 7,697 shares of the financial services provider’s stock after selling 231 shares during the quarter. Transcend Wealth Collective LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $1,157,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Schnieders Capital Management LLC bought a new stake in iShares Nasdaq Biotechnology ETF during the first quarter valued at $219,000. Mercer Global Advisors Inc. ADV boosted its position in iShares Nasdaq Biotechnology ETF by 53.6% during the first quarter. Mercer Global Advisors Inc. ADV now owns 2,520 shares of the financial services provider’s stock valued at $379,000 after acquiring an additional 879 shares during the last quarter. Essex Financial Services Inc. boosted its position in shares of iShares Nasdaq Biotechnology ETF by 5.8% during the 1st quarter. Essex Financial Services Inc. now owns 6,585 shares of the financial services provider’s stock worth $991,000 after purchasing an additional 362 shares in the last quarter. WealthPLAN Partners LLC boosted its position in shares of iShares Nasdaq Biotechnology ETF by 3.4% during the 1st quarter. WealthPLAN Partners LLC now owns 30,573 shares of the financial services provider’s stock worth $4,594,000 after purchasing an additional 1,019 shares in the last quarter. Finally, Cookson Peirce & Co. Inc. bought a new position in shares of iShares Nasdaq Biotechnology ETF during the 1st quarter worth about $283,000. 75.58% of the stock is currently owned by institutional investors and hedge funds.

IBB stock opened at $160.51 on Thursday. The stock’s 50-day moving average is $151.76. iShares Nasdaq Biotechnology ETF has a 1 year low of $125.18 and a 1 year high of $174.04.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: Price-Sales Ratio

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.